IBB - Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho, 4710-057, Braga, Portugal.
Adv Exp Med Biol. 2011;715:351-67. doi: 10.1007/978-94-007-0940-9_22.
Microbial infections resulting from bacterial adhesion to biomaterial surfaces have been observed on almost all medical devices. Biofilm infections pose a number of clinical challenges due to their resistance to immune defence mechanisms and antimicrobials, and, regardless of the sophistication of the implant, all medical devices are susceptible to microbial colonisation and infection. Research efforts are currently directed towards eliminating or reducing infection of medical devices. Strategies to prevent biofilm formation include physiochemical modification of the biomaterial surface to create anti-adhesive surfaces, incorporation of antimicrobial agents into medical device polymers, mechanical design alternatives, and release of antibiotics. Nevertheless, the success of these alternatives has been modest, mainly due to the various environments into which devices are placed and the diversity of ways in which organisms can colonise surfaces. Biosurfactants have been reported as a promising strategy as they effectively inhibit bacterial adhesion and retard biofilm formation, and are thus potentially useful as a new generation of anti-adhesive and antimicrobial coatings for medical devices.
微生物感染是由细菌黏附在生物材料表面引起的,几乎所有的医疗器械上都有这种现象。生物膜感染是一个临床挑战,因为它们对免疫防御机制和抗菌药物具有抗性,而且无论植入物的复杂程度如何,所有医疗器械都容易受到微生物的定植和感染。目前的研究工作致力于消除或减少医疗器械的感染。预防生物膜形成的策略包括对生物材料表面进行物理化学改性以创建抗黏附表面,将抗菌剂掺入医疗器械聚合物中,采用机械设计替代方案以及释放抗生素。然而,这些替代方法的效果并不理想,主要是因为器械所处的各种环境以及生物体在表面定植的多种方式。生物表面活性剂已被报道为一种很有前途的策略,因为它们可以有效地抑制细菌黏附并延缓生物膜的形成,因此有望成为新一代用于医疗器械的抗黏附和抗菌涂层。